Sun Pharma Completes Taro Merger Sun Pharma Completes Taro Merger PR Newswire MUMBAI, India and PRINCETON, N.J., June 24, 2024 Combined entity is better positioned to compete in increasingly...
Taro Shareholders Approve Merger with Sun Pharma Taro Shareholders Approve Merger with Sun Pharma PR Newswire MUMBAI, India and NEW YORK, May 23, 2024 MUMBAI, India and NEW YORK, May 23, 2024...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today provided unaudited financial results for the quarter and year ended March 31, 2024. Quarter ended March 31, 2024...
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2024, after the close of market on Monday, May 20, 2024. The...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today announced that leading independent proxy advisory firms Institutional Shareholder Services (ISS) and Glass Lewis & Co...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Taro Pharmaceutical Industries Ltd. (NYSE...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today announced that it has called an extraordinary general meeting of its shareholders (the Extraordinary General Meeting), to...
StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Free Report) in a research report sent to investors on Wednesday morning. The firm issued a strong-buy rating...
StockNews.com started coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a strong-buy...